📰 Psychedelics News

Curated updates on microdosing, research, policy, and community.

Filters

2025-08-06 OPEN Foundation

Germany’s Landmark Compassionate Use Program for Psilocybin: A New Wave for Psychedelic Medicine in Europe

In a bold move for European mental health care, Germany has become the first country in the EU to approve psilocybin therapy for patients with treatment-resistant depression outside of clinical trials!This decision, m...

2025-08-05 Psychedelics Today

GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin

More people than ever are taking GLP-1 receptor agonists—drugs like Ozempic (semaglutide), Wegovy, and Mounjaro. These medications, originally developed for type 2 diabetes, are now widely prescribed for weight loss. ...

2025-08-05 DoubleBlind Magazine

Ozzy Osbourne Talked to a Horse for an Hour High on Acid

PLUS a sneak peek on our upcoming story about the late great Jonathan Ott. [...] Read More... The post Ozzy Osbourne Talked to a Horse for an Hour High on Acid appeared first on DoubleBlind Mag.

2025-08-01 Microdosing Institute

Health-related behavioral changes following the use of psychedelics in naturalistic settings

This cross-sectional study (n=2,510) of US adults with psychedelic experience found that participants retrospectively reported widespread improvements in health behaviours including reduced alcohol (66%) and tobacco (...

Microdosing Research
2025-08-01 DoubleBlind Magazine

Wait, Mormons Are Allowed to Use Ketamine?

The LDS Church's health code forbids "intoxicating substances." So why are a gnumber of Mormons turning to ketamine therapy for healing? [...] Read More... The post Wait, Mormons Are Allowed to Use Ketamine? appeared ...

2025-07-31 Psychedelics Today

Mareesa Stertz & Tania Abdul – Sphinx Gate: Know Thyself at Burning Man

In this episode, Joe Moore is joined by Mareesa Stertz and Tania Abdul, the visionaries behind Sphinx Gate, one of Burning Man 2025’s most ambitious and mythic art installations. Inspired by The NeverEnding Story, Sph...

2025-07-31 Psychedelics Today

Psilocybin Enters German Psychiatry: A Clinical Milestone for Mental Health

Germany’s decision to permit psilocybin therapy for patients with treatment-resistant depression—under a compassionate use policy—marks a pivotal shift in European drug policy. It may set a precedent for others in the...

2025-07-31 Psychedelic Press (Substack)

Psilocybin Summer

An excerpt from Strange Attractor: The Hallucinatory Life of Terence McKenna by Graham St John

2025-07-30 DoubleBlind Magazine

Ayahuasca Gives You Wings

Professional athletes claim that ayahuasca helps them achieve the highest level of performance. But is it true? [...] Read More... The post Ayahuasca Gives You Wings appeared first on DoubleBlind Mag.

2025-07-30 Psychedelics Today

Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices

In this episode of Psychedelics Today, Joe Moore sits down with Chad Charles — educator, mentor, and practitioner specializing in 5-MeO-DMT therapy. Chad shares his decade-long journey working with 5-MeO-DMT, emphasiz...

2025-07-28 DoubleBlind Magazine

Mushrooms Are Leading LA’s Fire Remediation

PLUS a sneak peek on Friday's story about ketamine and Mormonism. [...] Read More... The post Mushrooms Are Leading LA’s Fire Remediation appeared first on DoubleBlind Mag.

2025-07-25 DoubleBlind Magazine

Searching for Freedom on the Road with the Dead

Ahead of the Dead’s 60th, one writer reflects on what it *actually* means to chase freedom on the road. [...] Read More... The post Searching for Freedom on the Road with the Dead appeared first on DoubleBlind Mag.

2025-07-25 Psychedelic Overground

Smothering Competition or Protecting Progress?

Let’s be clear: I’m not neutral on drug patents. They’re supposed to protect innovation. In practice, they exist to protect profit by legally enforcing monopolies and stifling competition. Some of the worst offende...

2025-07-24 Psychedelics Today

Alan Davis – Psychedelic Research and Patient Safety at Ohio State & Exploring Ibogaine’s Potential

In this episode of Psychedelics Today, Joe Moore sits down with Alan Davis, Associate Professor at Ohio State University, to explore the evolving landscape of Ibogaine research and its therapeutic potential. Alan offe...

2025-07-24 ScienceDaily Psychedelics

People with eating disorders say cannabis and psychedelics help more than antidepressants

A massive global survey has revealed that people with eating disorders often turn to cannabis and psychedelics like magic mushrooms and LSD to ease their symptoms, rating them more effective than traditional medicatio...